2seventy Bio Stock Beneish M Score

TSVT Stock  USD 4.96  0.01  0.20%   
This module uses fundamental data of 2Seventy Bio to approximate the value of its Beneish M Score. 2Seventy Bio M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out 2Seventy Bio Piotroski F Score and 2Seventy Bio Altman Z Score analysis.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.
  
At this time, 2Seventy Bio's Net Debt is comparatively stable compared to the past year. Debt To Equity is likely to gain to 1.64 in 2025, whereas Net Debt To EBITDA is likely to drop (0.83) in 2025. At this time, 2Seventy Bio's Receivables Turnover is comparatively stable compared to the past year. Shareholders Equity Per Share is likely to gain to 5.48 in 2025, whereas Free Cash Flow Yield is likely to drop (1.04) in 2025.
At this time, it appears that 2Seventy Bio is an unlikely manipulator. The earnings manipulation may begin if 2Seventy Bio's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by 2Seventy Bio executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of 2Seventy Bio's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.84
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables

1.05

Focus
Asset Quality

1.16

Focus
Expense Coverage

1.11

Focus
Gross Margin Strengs

1.15

Focus
Accruals Factor

1.11

Focus
Depreciation Resistance

0.85

Focus
Net Sales Growth

0.94

Focus
Financial Leverage Condition

1.23

Focus

2Seventy Bio Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if 2Seventy Bio's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables15.3 M15.4 M
Slightly Down
Slightly volatile
Total Revenue108.8 M115.4 M
Notably Down
Slightly volatile
Total Assets574.1 M650.2 M
Fairly Down
Slightly volatile
Total Current Assets192.8 M273.4 M
Way Down
Slightly volatile
Non Current Assets Total381.3 M376.8 M
Fairly Up
Slightly volatile
Property Plant Equipment47.7 M50.2 M
Notably Down
Slightly volatile
Depreciation And Amortization10.7 M9.3 M
Fairly Up
Slightly volatile
Selling General Administrative86.4 M82.7 M
Sufficiently Up
Slightly volatile
Total Current Liabilities66.8 M53.8 M
Fairly Up
Slightly volatile
Non Current Liabilities Total252.6 M287.9 M
Fairly Down
Slightly volatile
Net Debt168.8 M163.5 M
Sufficiently Up
Slightly volatile
Short Term Debt21.8 M30.4 M
Way Down
Slightly volatile
Gross Profit Margin0.960.8315
Fairly Up
Slightly volatile

2Seventy Bio Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between 2Seventy Bio's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards 2Seventy Bio in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find 2Seventy Bio's degree of accounting gimmicks and manipulations.

About 2Seventy Bio Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

10.7 Million

At this time, 2Seventy Bio's Depreciation And Amortization is comparatively stable compared to the past year.

2Seventy Bio Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as 2Seventy Bio. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
202020212022202320242025 (projected)
Net Receivables10.7M17.0M21.0M13.4M15.4M15.3M
Total Revenue248.1M54.5M91.5M100.4M115.4M108.8M
Total Assets312.6M759.7M656.7M565.4M650.2M574.1M
Total Current Assets25.1M291.6M300.9M237.8M273.4M192.8M
Net Debt255.2M151.8M199.1M181.7M163.5M168.8M
Short Term Debt30.6M19.5M11.2M26.4M30.4M21.8M
Operating Income(144.6M)(313.9M)(262.9M)(216.7M)(195.0M)(204.8M)
Investments(22.3M)15.4M34.5M(4.6M)(5.3M)(5.5M)

About 2Seventy Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.